02 May 2013

Drugs assessed for radiation treatment

The FDA will assess new drugs for the treatment of radiation exposure.

The drugs, known as leukocyte growth factors, will be the subject of a Friday meeting of an advisory committee to the US Food and Drug Administration. Treatment with Amgen's Neupogen and Neulasta, Teva's Tbo-filgrastim and Sanofi's Leukine, may decrease death rates from radiation exposure, according to FDA staff documents released ahead of the meeting.

Neupogen, which like the other drugs in the class is given by injection, has been tested in monkeys exposed to radiation by researchers at the National Institutes of Health and the University of Maryland.

Friday's hearing was prompted by data from the trial showing that the drug reduced mortality following irradiation of the animals. Amgen spokesperson Ashleigh Koss said the company provided additional nonclinical data from studies using the drugs in radiation-exposed animals, and an overview of literature case studies of their use in victims of radiological accidents.

She declined to comment on whether Amgen planned to participate in any future trials of Neupogen or Neulasta as treatments for radiation exposure.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules